The level of committed hypomethylated CD4+ T cells were increased in patients with low, non-muscle invasive pT stages as compared to those from patients with muscle invasive pT2 tumours (Fig. 6), which was most prominent in Th1 cells. The gene discussed is CD4; the disease is neoplasm.